Pharmaceutical Janssen, which belongs to Johnson & Johnson, has revealed news about your vaccine. As Joaquín Duato, vice president of the Executive Committee of the multinational, has communicated in a conference, andIt will be available in 2021 and will be priced below $ 10 (about 8.5 euros).
One billion vaccines
Thus, the manager stated that “during the next six months there will be good news, we can see how these effective vaccines will be available for the public. “This pharmaceutical company has worked the supply chain to be able to offer one billion cures in 2021 through a collaborative network.
Last week, Pfizer was the first to report success of your vaccine. This week has been the Moderna turn. Despite the competition, for Duato it is something positive: “It is not a competitive situation, it is a social issue and a global crisis in which we will need several vaccines, not just one, because we must vaccinate millions of people. “
In addition, the pharmaceutical company stressed that will not focus on achieving maximum benefit: “We will search guarantee access to the vaccine in all territories, the price will not be more than $ 10 per vaccine. “
Trials in Spain
Last Wednesday, the Spanish Agency for Medicines and Health Products authorized the clinical trial of this vaccine in phase 3. These tests will be carried out in the University of Navarra Clinic, the La Paz University Hospital, the Quirón University Hospital Health Madrid, the University Hospital of La Princesa, the Hospital Quirón Salud Barcelona, the Vall d’Hebron University Hospital, the Hospital Clinic of Barcelona and the Germans Trias i Pujol Hospital in Badalona.